Drugs and chemotherapeutics have helped to manage devastating impacts of infectious
diseases since the concept of 'magic bullet'. The World Health Organization estimates about …

Highlights•Resistance and timely treatment are challenges for approved influenza
antivirals.•Structure insights on RNP functional domains aid development of novel …

The influenza virus causes one of the most prevalent and lethal infectious viral diseases of
the respiratory system; the disease progression varies from acute self-limiting mild fever to …

Influenza A viruses cause significant morbidity and mortality annually, and the threat of a
pandemic underscores the need for new therapeutic strategies. Here, we briefly discuss …

Influenza viruses are a leading cause of morbidity and mortality worldwide despite the
availability of an effective vaccine. The emergence of highly pathogenic avian influenza …

Introduction: Influenza is a serious health threat for people of all ages. The causative virus is
evolving continuously and the risk of an unexpected mutant, which cannot be controlled by …

Please cite this paper as: Hayden FG.(2012) Newer Influenza Antivirals, Biotherapeutics and
Combinations. Influenza and Other Respiratory Viruses 7 (Suppl. 1), 63–75. This summary …

Influenza is a century-old disease that continues to baffle humans by its frequently changing
nature, seasonal epidemics, and occasional pandemics. Approximately 9% of the world's …

Influenza viruses (IVs) threaten global human health due to the high morbidity, infection, and
mortality rates. Currently, the influenza drugs recommended by the Food and Drug …

Influenza is a severe cause of morbidity and mortality throughout the world, resulting in
annual outbreaks in all age ranges of the population. With an extensive animal reservoir the …